Moleculin Biotech (MBRX) Q2 2025 Earnings

13MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-2.85
-1.82
-0.78
0.25

Details

Expected EPS
-0.555
Actual EPS
-0.69
Surprise EPS
-0.13
Surprise Percent
+24.32%

Description

Moleculin Biotech (MBRX) has reported earnings of -0.69 per share for Q2 2025.

0 Comments

Share your thoughts